Alishba Abbasi - Neurogenetics

Neurogenetics

Alishba Abbasi

Neurogenetic disorders are genetic and chromosomal alterations that affect the nervous system, affecting brain development, nerve function, and overall neurological well-being. Early intervention is crucial for a child's ability to acquire essential skills and independence. 

Along with lifelong healthcare management, which can only be achieved via a collaborative approach involving a multidisciplinary team of clinicians, scientists, psychologists, social workers and administrative staff in order to meet the specific needs of the individual and their family. The establishment of an integrated service that includes clinical assessment and diagnosis, molecular genetic testing and follow-up consultations would all need to be in place. 

Yet for many, this is unavailable. Either due to the expenses required, the ethical issues related to it, or due to the pace at which this field is advancing, which proves hard to keep up. Despite increased funding, there is a significant shortage of resources for research into rare diseases and the infrastructure for genetic testing. A lack of trained genetic counselors and specialists in rare diseases results in unequal access to specialized care, especially between urban and rural areas.

Ethical challenges arise in two main ways: first, predictive genetic testing can inform asymptomatic relatives about their risk status, necessitating guidelines to uphold patient autonomy and support informed decision-making; second, diagnoses can significantly impact healthcare decisions for both patients and their first-degree relatives and can also psychologically affect families as these complex conditions at times make individuals feel isolated.

Rare neurological diseases are often attributed to genetic anomalies, and genetic diagnosis has become vital for neurogenetics diseases. To enhance existing infrastructure, education and research networks must be developed, necessitating time and support from institutions and government bodies to raise awareness of these diseases and keep clinicians updated. Genetic screening may also benefit families with specific genetic predispositions to certain neurogenetic disorders, enabling them to take proactive steps to improve their quality of life.